ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
First patient dosed for Phase I/II trial of avapritinib in advanced GIST biospectrumasia
August 26, 2019CStone announces on a registrational bridging study in China which includes a Phase I dose-escalation study and Phase II dose-expansion study to evaluate safety, pharmacokinetics and efficacy of avapritinib in patients with metastatic gastrointestinal str
Pharma Sources Insight January 2025
